NextPlat (NASDAQ: NXPL) announces the launch of the OPKO Health online store

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it will enable online sales of OPKO Health Europe, a subsidiary of OPKO Health (NASDAQ: OPK) products in China through a new e-commerce distribution agreement. Under the terms of the agreement, NextPlat will launch an online store in China under the OPKO Health brand on Alibaba Group Holding Limited’s (NYSE: BABA) e-commerce platform Tmall Global, offering a range of nutraceutical and veterinary products sold and distributed by OPKO Europe. “NextPlat is focused on enabling companies in a range of high-growth sectors, such as healthcare and consumer products, to capitalize on the enormous opportunities presented by global e-commerce. Having successfully built a significant portfolio of products that promote human and animal health, we believe that OPKO Europe is the ideal customer for our new e-commerce expansion program,” said Charles M. Fernandez, Executive Chairman and CEO of NextPlat. “By leveraging our knowledge, capabilities and expanded relationships with Alibaba on the Internet, we can uniquely provide OPKO Europe with a reliable and effective way to quickly start selling its products online to potentially millions of new consumers in China.”

To read the full press release, visit https://ibn.fm/riCK1

About NextPlat Corp.

NextPlat is a global e-commerce platform designed to tap into a wide range of rapidly growing sectors and markets, including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company aims to help businesses sell goods online, domestically and internationally, enabling customers and partners to optimize their e-commerce presence and revenues. NextPlat currently operates an e-commerce communications division offering voice, data, tracking and IoT products and services globally, as well as pharmaceutical and healthcare data management services in the United States.

NOTE FOR INVESTORS: For the latest news and updates on NXPL, visit the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform focusing on the latest developments in the biotechnology (BioTech), biomedical sciences (BioMed) and life sciences sectors. It is one of over 60 brands on the market Dynamic brand portfolio @ INB it delivers: : (1) access to an extensive network of wired solutions through InvestorWire to efficiently and effectively reach countless target markets, demographic groups and diverse industries; (2) distribution of articles and editorials to over 5,000 outlets; (3) improved press release refinement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full range of customized corporate communications solutions. With its broad reach and experienced team of journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide range of investors, influencers, consumers, journalists and the general public. By cutting through the information overload in today’s marketplace, BMW provides its customers with unrivaled brand recognition and awareness.

BMW is where breaking news, insightful content and useful information converge.

To receive text alerts from BioMedWire, “Biotech” at 844-397-5787 (US mobile phones only)

More information can be found at https://www.BioMedWire.com

Please read the full terms of use and disclaimers on the BioMedWire website that apply to all content provided by BMW, regardless of where it is published or republished: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]